Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Bioblast Pharma Ltd. (NASDAQ: ORPN).

Full DD Report for ORPN

You must become a subscriber to view this report.


Recent News from (NASDAQ: ORPN)

Bioblast Pharma Ltd. Corporate and Management Update
TEL AVIV, Israel and NEW YORK, July 26, 2018 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (Nasdaq:ORPN) is providing an update on business development activities as well as notice of an organization change that affects members of the board and management. As previously announced, the Company...
Source: GlobeNewswire
Date: July, 26 2018 16:15
Midday Gainers / Losers (05/18/2018)
Gainers:  ORPN +31% . MTEX +24% . TYHT +20% . EOLS +18% . QTNT +17% . VLRX +17% . WMLP +16% . AQMS +12% . EGY +13% . SDR +13% . More news on: Bio Blast Pharma, Mannatech, Incorporated, Shineco, Inc., , Stocks on the move, Read more ...
Source: SeekingAlpha
Date: May, 18 2018 12:51

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-101.221.18191.251.140123,527
2018-12-071.271.191.27211.130148,615
2018-12-061.26991.25251.271.2041,834
2018-12-051.251.271.281.246,183
2018-12-041.251.271.281.246,183

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-076353,54017.9379Cover
2018-12-062,1586,10835.3307Short
2018-12-0490096493.3610Short
2018-12-032005,9203.3784Cover
2018-11-301,0341,70560.6452Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ORPN.


About Bioblast Pharma Ltd. (NASDAQ: ORPN)

Logo for Bioblast Pharma Ltd. (NASDAQ: ORPN)

Not available

 

Contact Information

     

     

    Current Share Structure

    • Market Cap: $7,591,586 - 05/18/2018
    • Authorized: 50,000,000 - 05/01/2018
    • Issue and Outstanding: 3,359,109 - 05/01/2018

     


    Recent Filings from (NASDAQ: ORPN)

    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: July, 26 2018
    Annual and transition report of foreign private issuers under sections 13 or 15(d)
    Filing Type: 20-FFiling Source: edgar
    Filing Date: April, 23 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 06 2018
    Amendment to the SC 13G filing
    Filing Type: SC 13G/AFiling Source: edgar
    Filing Date: February, 14 2018
    Amendment to the SC 13G filing
    Filing Type: SC 13G/AFiling Source: edgar
    Filing Date: February, 14 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: December, 21 2017
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: November, 16 2017
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: November, 02 2017
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: October, 16 2017
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: September, 25 2017

     

     


    Daily Technical Chart for (NASDAQ: ORPN)

    Daily Technical Chart for (NASDAQ: ORPN)


    Stay tuned for daily updates and more on (NASDAQ: ORPN)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: ORPN)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ORPN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ORPN and does not buy, sell, or trade any shares of ORPN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/